Agios Pharmaceuticals AGIO
$ 44.83
0.0%
Quarterly report 2024-Q3
added 10-31-2024
Agios Pharmaceuticals Operating Income 2011-2024 | AGIO
Annual Operating Income Agios Pharmaceuticals
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
-391 M | -389 M | -378 M | -336 M | -316 M | -362 M | -321 M | -201 M | -119 M | -54.1 M | -38.9 M | -23 M | -16.6 M |
All numbers in USD currency
Indicator range from annual reports
Maximum | Minimum | Average |
---|---|---|
-16.6 M | -391 M | -227 M |
Quarterly Operating Income Agios Pharmaceuticals
2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
-103 M | -106 M | -92.1 M | - | -101 M | -93.7 M | -90.6 M | - | -91.1 M | -97.6 M | -101 M | - | -91.2 M | -91.2 M | -91.2 M | -92.4 M | -80.3 M | -83.3 M | -87 M | -106 M | -109 M | -114 M | -97.5 M | -96.4 M | -99.2 M | -72.9 M | -94 M | -90.1 M | -79 M | -84.6 M | -67 M | -57.4 M | -63.5 M | -56.5 M | -23.6 M | -40.9 M | -40.5 M | -32.1 M | -5.2 M | -26.7 M | 3.21 M | -18.3 M | -12.3 M | -12.2 M | -11.1 M | -8.53 M | -7.05 M | -6.5 M | -5.11 M | -6.12 M | -5.26 M | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
Maximum | Minimum | Average |
---|---|---|
3.21 M | -114 M | -63.3 M |